KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Enterprise Value (2016 - 2026)

Medtronic's Enterprise Value history spans 13 years, with the latest figure at -$936.0 million for Q1 2026.

  • For Q1 2026, Enterprise Value rose 24.52% year-over-year to -$936.0 million; the TTM value through Jan 2026 reached -$936.0 million, up 24.52%, while the annual FY2025 figure was -$8.7 billion, 11.98% down from the prior year.
  • Enterprise Value for Q1 2026 was -$936.0 million at Medtronic, up from -$1.1 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$936.0 million in Q1 2026 and bottomed at -$11.2 billion in Q1 2022.
  • The 5-year median for Enterprise Value is -$2.0 billion (2022), against an average of -$4.7 billion.
  • The largest YoY upside for Enterprise Value was 87.05% in 2024 against a maximum downside of 562.9% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$4.7 billion in 2022, then surged by 75.83% to -$1.1 billion in 2023, then dropped by 4.27% to -$1.2 billion in 2024, then increased by 8.02% to -$1.1 billion in 2025, then grew by 13.17% to -$936.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Enterprise Value are -$936.0 million (Q1 2026), -$1.1 billion (Q4 2025), and -$1.0 billion (Q3 2025).